跳到主要內容
Rallybid

已批出合約

Managed Service for Blood Grouping Assays and Consumables

Gloucestershire Hospitals NHS Foundation Trust已就「Managed Service for Blood Grouping Assays and Consumables」批出此合約。

此招標已不再接受新的投標。 類似的進行中招標

用淺白語言說明,這項招標是什麼?

此公告尚未翻譯,以原文語言顯示。

同類招標的過往批出紀錄說明了甚麼?

  • 半數同類合約的批出金額介乎 £839,328 至 £1,820,106,中位數為 £1,142,000。
  • CONSTELLIA LIMITED 在過去三年從此採購方取得 3 份同類合約。

根據過去 36 個月 19 項批出紀錄:相同工種、相同地區、金額相近。可信程度:中。以上只反映過往情況,並非預測結果。 批出合約資料

誰贏得這項招標,金額是多少?

  • ORTHO-CLINICAL DIAGNOSTICS (trading as QuidelOrtho)獲批出此合約,金額為£1,091,844,日期為2026年9月18日。

公告全文

原文(English)

Managed Service for Blood Grouping Assays and Consumables

Provision of automated blood transfusion analysers, associated reagents, consumables, maintenance and support services for Gloucestershire Hospitals NHS Foundation Trust. This contract is being awarded via the NHSSC PCR 2015 Laboratory Diagnostics, Point of Care Testing & Pathology Managed Services OJEU REF - 2023/S 000-028831 Framework Agreement using the Direct Award mechanism. The contract covers the supply, installation, validation, calibration, maintenance and ongoing support of automated transfusion analysers used by Gloucestershire Hospitals NHS Foundation Trust to perform blood grouping, antibody screening, further investigations and serological cross-matching. These functions are critical to the safe provision of blood and blood components for transfusion and support compliance with relevant regulatory and clinical standards. The service includes the provision of analysers, reagents, consumables, quality control materials, software support and upgrades, preventative maintenance, technical support, fault resolution and user training. The supplier will also provide ongoing contract support, manage reagent supply in line with clinical activity, investigate analytical errors and equipment issues, and deliver agreed service levels and performance standards. Automated testing and the electronic transfer of validated results are mandatory requirements for the Electronic Issue (EI) of blood. EI enables the rapid issue of compatible blood products, reducing blood wastage, improving stock management and supporting the timely treatment of patients across emergency departments, operating theatres, maternity services, critical care units, haematology services and other clinical areas. The contract supports a Trust-wide critical clinical service for patients requiring transfusion, patients at risk of major blood loss, and antenatal patients and their babies. Continuity of analyser availability, reagent supply and technical support is essential to maintaining patient safety, regulatory compliance and operational resilience. Any interruption to the service could adversely affect the Trust's ability to provide timely and safe transfusion support, potentially impacting emergency care, surgical procedures, maternity pathways and other critical patient services. The contract is therefore essential to ensuring the uninterrupted delivery of a safe, reliable and compliant transfusion service across Gloucestershire Hospitals NHS Foundation Trust Estimated Annual Test Performed • Blood Group 50,000 • Antibody Screen 50,000 • Antibody Panel 1,500 • Antibody Titre 15 • Crossmatch 1500 • RhK Phenotype 1000 • Other Phenotypes 180 • Direct Antiglobulin Test 650

以電郵接收這些招標

每天一封電郵,列出你所選行業及地區的新招標。無需帳戶或密碼。

我們會先以電郵發送確認連結。在你使用連結之前,不會發送任何其他內容。 私隱聲明

快速解答

這項招標何時截止?

已於2026年9月22日截止。

這份合約價值多少?

採購方估計價值為£1,310,213。

採購方是誰?

採購方是Gloucestershire Hospitals NHS Foundation Trust。

類似的進行中招標